These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23105966)

  • 21. It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.
    Mullins CD; Sanchez RJ
    J Manag Care Pharm; 2011; 17(9 Suppl A):S03-4. PubMed ID: 22074667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Multilevel Approach to Stakeholder Engagement in the Formulation of a Clinical Data Research Network.
    Boyer AP; Fair AM; Joosten YA; Dolor RJ; Williams NA; Sherden L; Stallings S; Smoot DT; Wilkins CH
    Med Care; 2018 Oct; 56 Suppl 10 Suppl 1(10 Suppl 1):S22-S26. PubMed ID: 30074947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective stakeholder engagement: design and implementation of a clinical trial (SWOG S1415CD) to improve cancer care.
    Barger S; Sullivan SD; Bell-Brown A; Bott B; Ciccarella AM; Golenski J; Gorman M; Johnson J; Kreizenbeck K; Kurttila F; Mason G; Myers J; Seigel C; Wade JL; Walia G; Watabayashi K; Lyman GH; Ramsey SD
    BMC Med Res Methodol; 2019 Jun; 19(1):119. PubMed ID: 31185918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective stakeholder participation in setting research priorities using a Global Evidence Mapping approach.
    Clavisi O; Bragge P; Tavender E; Turner T; Gruen RL
    J Clin Epidemiol; 2013 May; 66(5):496-502.e2. PubMed ID: 22819249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The economics of comparative effectiveness studies: societal and private perspectives and their implications for prioritizing public investments in comparative effectiveness research.
    Meltzer D; Basu A; Conti R
    Pharmacoeconomics; 2010; 28(10):843-53. PubMed ID: 20831292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methods for Incorporating Stakeholder Engagement into Clinical Trial Design.
    Ehlers AP; Davidson GH; Deeney K; Talan DA; Flum DR; Lavallee DC
    EGEMS (Wash DC); 2017 May; 5(1):4. PubMed ID: 29930955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engaging veteran stakeholders to identify patient-centred research priorities for optimizing implementation of lung cancer screening.
    Yan A; Hooyer K; Asan O; Flower M; Whittle J
    Health Expect; 2022 Feb; 25(1):408-418. PubMed ID: 34890474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers.
    Facey K; Bradbury I; Laking G; Payne E
    Health Technol Assess; 2007 Oct; 11(44):iii-iv, xi-267. PubMed ID: 17999839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IMPACCT Kids' Care: a real-world example of stakeholder involvement in comparative effectiveness research.
    Likumahuwa-Ackman S; Angier H; Sumic A; Harding RL; Cottrell EK; Cohen DJ; Nelson CA; Burdick TE; Wallace LS; Gallia C; DeVoe JE
    J Comp Eff Res; 2015 Aug; 4(4):351-7. PubMed ID: 26274796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A model for incorporating patient and stakeholder voices in a learning health care network: Washington State's Comparative Effectiveness Research Translation Network.
    Devine EB; Alfonso-Cristancho R; Devlin A; Edwards TC; Farrokhi ET; Kessler L; Lavallee DC; Patrick DL; Sullivan SD; Tarczy-Hornoch P; Yanez ND; Flum DR;
    J Clin Epidemiol; 2013 Aug; 66(8 Suppl):S122-9. PubMed ID: 23849146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stakeholder assessment of comparative effectiveness research needs for Medicaid populations.
    Fischer MA; Allen-Coleman C; Farrell SF; Schneeweiss S
    J Comp Eff Res; 2015 Sep; 4(5):465-71. PubMed ID: 26388438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Setting priorities for comparative effectiveness research in inflammatory bowel disease: results of an international provider survey, expert RAND panel, and patient focus groups.
    Cheifetz AS; Melmed GY; Spiegel B; Talley J; Devlin SM; Raffals L; Irving PM; Jones J; Kaplan GG; Kozuch P; Sparrow M; Velayos F; Baidoo L; Bressler B; Siegel CA
    Inflamm Bowel Dis; 2012 Dec; 18(12):2294-300. PubMed ID: 22337359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stakeholder Engagement in Planning the Design of a National Needs Assessment for Cardiovascular Disease Prevention and Management in Nepal.
    Archana S; Karmacharya BM; Rashmi M; Abhinav V; Meghnath D; Natalia O; Rajeev S; Prajjwal P; Annette F; David C; Swornim B; Roman XD; Donna S; Rajendra K
    Glob Heart; 2019 Jun; 14(2):181-189. PubMed ID: 31324373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation.
    Cooper KL; Meng Y; Harnan S; Ward SE; Fitzgerald P; Papaioannou D; Wyld L; Ingram C; Wilkinson ID; Lorenz E
    Health Technol Assess; 2011 Jan; 15(4):iii-iv, 1-134. PubMed ID: 21276372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effectiveness research in cancer genomics and precision medicine: current landscape and future prospects.
    Simonds NI; Khoury MJ; Schully SD; Armstrong K; Cohn WF; Fenstermacher DA; Ginsburg GS; Goddard KA; Knaus WA; Lyman GH; Ramsey SD; Xu J; Freedman AN
    J Natl Cancer Inst; 2013 Jul; 105(13):929-36. PubMed ID: 23661804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lessons from comparative effectiveness research methods development projects funded under the Recovery Act.
    Zurovac J; Esposito D
    J Comp Eff Res; 2014 Nov; 3(6):601-7. PubMed ID: 25494566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research.
    Goddard KA; Knaus WA; Whitlock E; Lyman GH; Feigelson HS; Schully SD; Ramsey S; Tunis S; Freedman AN; Khoury MJ; Veenstra DL
    Genet Med; 2012 Jul; 14(7):633-42. PubMed ID: 22516979
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.